Form C - Offering Statement:
SEC Accession No. 0001644600-21-000059
Filing Date
2021-05-25
Accepted
2021-05-25 14:03:53
Documents
8

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 8905
2 OFFERING MEMORANDUM SafeRxOMMay25Final.pdf EX-99 1004936
3 FINANCIALS SafeRxFinancialsMay25.pdf EX-99 795840
4 SUBSCRIPTION AGREEMENT SafeRxSubscriptionAgmtMay25.pdf EX-99 655807
5 OFFERING PAGE SafeRxOfferingPageFinal.pdf EX-99 1920557
6 INVESTOR DECK SafeRxPitchDeckMay25.pdf EX-99 7046448
7 OFFERING PAGE VIDEO TRANSCRIPT SafeRxOPTranscriptMay25.pdf EX-99 223194
8 MARLO VIDEO TRANSCRIPT SafeRxMarloTranscriptMay25.pdf EX-99 511093
  Complete submission text file 0001644600-21-000059.txt   16608587
Mailing Address PO BOX #2102 LENOX MA 01240
Business Address PO BOX #2102 LENOX MA 01240 13523754849
SafeRx Pharmaceuticals Inc. (Filer) CIK: 0001850523 (see all company filings)

EIN.: 851617189 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-28153 | Film No.: 21959484